Abeer Mohamed Ahmed Zahran
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Abeer Mohamed Ahmed Zahran has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Abeir Osman Dabbous
Audiology Unit, Department of Otolaryngology, Faculty of Medicine, Cairo University, Kasr Al Ainy, Giza, Egypt
2 shared publications Hussein S. El-Fishawy
2 shared publications- Mona Hamdy
Cairo University, Cairo, Egypt
2 shared publications - Noha Mahmoud Abdel Baki
Department of Rheumatology and Rehabilitation, Faculty of Medicine, Cairo University, 7 Omar EbnAbiRabeah Street, El Haram, Kasr Al Ainy, Giza, 12311, Egypt
2 shared publications - Rabab Ahmed Koura
Audiology Unit, Department of Otolaryngology, Faculty of Medicine, Beni Suef University, Beni Suef, Egypt
2 shared publications - Amal H. Eissa
Clinical Pathology Department, Helwan University School of Medicine, Cairo, Egypt
1 shared publication
Latest Publications
- Open Access
- 1 December 2021
- Published by Elsevier in Journal of Radiation Research and Applied Sciences
- Vol. 14 (1) , 171-178
Assessment of T Regulatory cells in Egyptian patients with Behcet’s disease as a prognostic marker of Uveitis
- 1 December 2021
- Published by Elsevier in Journal of Radiation Research and Applied Sciences
- Vol. 14 (1) , 171-178
Open AccessAssessment of T Regulatory cells in Egyptian patients with Behcet’s disease as a prognostic marker of Uveitis
- Open Access
- 8 March 2021
- Published by Springer Nature in Egyptian Rheumatology and Rehabilitation
- Vol. 48 (1) , 1
Correction to: Cervical vestibular evoked myogenic potential and high-frequency audiometry results in Behçet’s disease
An amendment to this paper has been published and can be accessed via the original article.
- 8 March 2021
- Published by Springer Nature in Egyptian Rheumatology and Rehabilitation
- Vol. 48 (1) , 1
Open AccessCorrection to: Cervical vestibular evoked myogenic potential and high-frequency audiometry results in Behçet’s disease
An amendment to this paper has been published and can be accessed via the original article.
- Open Access
- 12 January 2021
- Published by Springer Nature in Egyptian Rheumatology and Rehabilitation
- Vol. 48 (1) , 1-9
Cervical vestibular evoked myogenic potential and high-frequency audiometry results in Behçet’s disease
- 12 January 2021
- Published by Springer Nature in Egyptian Rheumatology and Rehabilitation
- Vol. 48 (1) , 1-9
Open AccessCervical vestibular evoked myogenic potential and high-frequency audiometry results in Behçet’s disease
- Open Access
- 13 August 2020
- Published by Portal de Periódicos UFU - Universidade Federal de Uberlandia in Bioscience Journal
- Vol. 36 (5) , 1750-1759
Assessment of circulating MCP-1 level and 2518A>G gene polymorphism in systemic lupus erythematosus
Lupus nephritis (LN) is a major contributor to morbidity and mortality in patients with Systemic Lupus Erythematosus (SLE). This study aims to investigate the possible role of a functional polymorphism in the regulatory region of the monocyte chemo-attractant protein-1 (MCP-1) gene and MCP-1 blood level in the diagnosis of LN and in correlating the MCP-1 blood levels with disease activity. The study included 56 SLE patients and 56 controls. All the SLE patients suffered from LN. An analysis of MCP-1 gene polymorphism by polymerase chain reaction was performed followed by restriction fragment length polymorphism (PCR-RFLP) analysis and MCP-1 blood level was determined using the ELISA technique. Calculation of Systemic Lupus Erythematosus Disease Activity Index (SLEDAI) was performed. Serologic tests included the determination of antinuclear antibody (ANA) and anti-double-stranded (ds) DNA antibodies, Complement C3 and C4 levels. A significant increase in the frequency of genotype A/G and a decrease in the frequency of genotype A/A were found among patients with active LN compared to inactive LN. There was a statistically significant difference in the blood level of MCP-1 between LN patients and controls. Also, MCP-1 blood levels were significantly higher in active LN patients than inactive LN. A significant positive linear correlation was detected between MCP-1 blood level and SLEDAI, creatinine, and 24 hours protein in LN patients. These results suggest that an A/G genotype together with the measurement of the blood level of MCP-1 can be a useful tool for detection and follow up of active LN.
- 13 August 2020
- Published by Portal de Periódicos UFU - Universidade Federal de Uberlandia in Bioscience Journal
- Vol. 36 (5) , 1750-1759
Open AccessAssessment of circulating MCP-1 level and 2518A>G gene polymorphism in systemic lupus erythematosus
Lupus nephritis (LN) is a major contributor to morbidity and mortality in patients with Systemic Lupus Erythematosus (SLE). This study aims to investigate the possible role of a functional polymorphism in the regulatory region of the monocyte chemo-attractant protein-1 (MCP-1) gene and MCP-1 blood level in the diagnosis of LN and in correlating the MCP-1 blood levels with disease activity. The study included 56 SLE patients and 56 controls. All the SLE patients suffered from LN. An analysis of MCP-1 gene polymorphism by polymerase chain reaction was performed followed by restriction fragment length polymorphism (PCR-RFLP) analysis and MCP-1 blood level was determined using the ELISA technique. Calculation of Systemic Lupus Erythematosus Disease Activity Index (SLEDAI) was performed. Serologic tests included the determination of antinuclear antibody (ANA) and anti-double-stranded (ds) DNA antibodies, Complement C3 and C4 levels. A significant increase in the frequency of genotype A/G and a decrease in the frequency of genotype A/A were found among patients with active LN compared to inactive LN. There was a statistically significant difference in the blood level of MCP-1 between LN patients and controls. Also, MCP-1 blood levels were significantly higher in active LN patients than inactive LN. A significant positive linear correlation was detected between MCP-1 blood level and SLEDAI, creatinine, and 24 hours protein in LN patients. These results suggest that an A/G genotype together with the measurement of the blood level of MCP-1 can be a useful tool for detection and follow up of active LN.